BJDX

Bluejay Diagnostics (BJDX)

About Bluejay Diagnostics (BJDX)

Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.

Details

Daily high

$5.40

Daily low

$4.01

Price at open

$4.20

52 Week High

$386.72

52 Week Low

$3.03

Market cap

2.5M

Dividend yield

0.00%

Volume

412,357

Avg. volume

188,099

P/E ratio

.00

Bluejay Diagnostics News